Cargando…
Gene dysregulation analysis builds a mechanistic signature for prognosis and therapeutic benefit in colorectal cancer
The implementation of cancer precision medicine requires biomarkers or signatures for predicting prognosis and therapeutic benefits. Most of current efforts in this field are paying much more attention to predictive accuracy than to molecular mechanistic interpretability. Mechanism-driven strategy h...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7883816/ https://www.ncbi.nlm.nih.gov/pubmed/32717065 http://dx.doi.org/10.1093/jmcb/mjaa041 |